471 related articles for article (PubMed ID: 9314617)
1. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
Carp JM; Onuma E; Das K; Gottlieb AB
Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
[TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
3. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease.
Friedman S; Marion JF; Scherl E; Rubin PH; Present DH
Inflamm Bowel Dis; 2001 Feb; 7(1):1-7. PubMed ID: 11233655
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Triple Combination Therapy for Recalcitrant Perineal Pyoderma Gangrenosum.
Shaath TS; Om A; Wolfe CM; Cohen GF
J Drugs Dermatol; 2019 Mar; 18(3):307-310. PubMed ID: 31020825
[TBL] [Abstract][Full Text] [Related]
5. Use of infliximab in pyoderma gangrenosum.
Hewitt D; Tait C
Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
[TBL] [Abstract][Full Text] [Related]
6. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
[TBL] [Abstract][Full Text] [Related]
7. [Pyoderma gangrenosum, a nonintestinal manifestation of Lesniowski-Crohn's disease in a 15 years old girl].
Müller L; Bala G; Kuczyńska R; Czerwionka-Szaflarska M
Med Wieku Rozwoj; 2006; 10(2):463-73. PubMed ID: 16825717
[TBL] [Abstract][Full Text] [Related]
8. A novel therapy for the treatment of pyoderma gangrenosum.
Azizan NZ; Gangaram HB; Hussein SH
Med J Malaysia; 2008 Mar; 63(1):51-4. PubMed ID: 18935734
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pyoderma gangrenosum with cyclosporine.
Matis WL; Ellis CN; Griffiths CE; Lazarus GS
Arch Dermatol; 1992 Aug; 128(8):1060-4. PubMed ID: 1497359
[TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum as initial manifestation of Graves' disease.
Livideanu C; Lipsker D; Paul C; Juillard J; Schubert B
Clin Exp Dermatol; 2006 Sep; 31(5):659-61. PubMed ID: 16780496
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
Egan LJ; Sandborn WJ; Tremaine WJ
Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
[TBL] [Abstract][Full Text] [Related]
12. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
13. Extraintestinal manifestations of Crohn's disease.
Juillerat P; Mottet C; Froehlich F; Felley C; Vader JP; Burnand B; Gonvers JJ; Michetti P
Digestion; 2005; 71(1):31-6. PubMed ID: 15711047
[TBL] [Abstract][Full Text] [Related]
14. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of postoperative pyoderma gangrenosum with cyclosporin.
Schöfer H; Baur S
J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):148-51. PubMed ID: 12046819
[TBL] [Abstract][Full Text] [Related]
16. Accelerated healing of pyoderma gangrenosum in Behçet patient treated with cyclosporine and split thickness skin graft.
Kim DW; Lee BI; Park SH
Ann Plast Surg; 2008 Nov; 61(5):552-4. PubMed ID: 18948785
[TBL] [Abstract][Full Text] [Related]
17. Refractory pyoderma gangrenosum of the orbit and the lacrimal sac.
Cordero-Coma M; Pérez-Moreiras JV; Toribio A; Alonso-Orcajo N; Calleja S; Franco M; Ruiz de Morales JG
Orbit; 2012 Aug; 31(4):249-51. PubMed ID: 22571540
[TBL] [Abstract][Full Text] [Related]
18. Atypical pyoderma gangresosum in inflammatory bowel disease. A severe diagnostic challenge.
Muñoz PS; Ugidos AF; Montiel PM; Yagüe TM; Garrido C; Herruzo JA
Rev Esp Enferm Dig; 2009 Aug; 101(8):585-7. PubMed ID: 19785502
[No Abstract] [Full Text] [Related]
19. Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease.
Uchino M; Ikeuchi H; Matsuoka H; Bando T; Takahashi Y; Takesue Y; Matsumoto T; Tomita N
Digestion; 2012; 85(4):295-301. PubMed ID: 22584791
[TBL] [Abstract][Full Text] [Related]
20. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
